| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 7.98e-13 | 5 | 78 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 4.78e-12 | 6 | 78 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | calcium ion binding | SELE JAG2 SELL EYS AMY1A AMY1B HEG1 AMY1C AMY2A AMY2B ENPP3 LRP2 LRP4 LTBP2 CBL LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 6.04e-12 | 749 | 78 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | chloride ion binding | 3.37e-09 | 16 | 78 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.09e-06 | 103 | 78 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 7.50e-06 | 120 | 78 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.12e-05 | 144 | 78 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.32e-04 | 200 | 78 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | microfibril binding | 2.24e-04 | 6 | 78 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | endopeptidase activity | PAPPA2 EEF1AKMT4-ECE2 ADAM21 ADAMTS15 PAPPA PGC ADAMTSL2 PCSK9 | 2.72e-04 | 430 | 78 | 8 | GO:0004175 |
| GeneOntologyMolecularFunction | apolipoprotein receptor binding | 3.12e-04 | 7 | 78 | 2 | GO:0034190 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.43e-04 | 85 | 78 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | fucose binding | 4.15e-04 | 8 | 78 | 2 | GO:0042806 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.74e-03 | 16 | 78 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 2.21e-03 | 18 | 78 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.73e-03 | 20 | 78 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 2.73e-03 | 20 | 78 | 2 | GO:0070492 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 2.93e-03 | 73 | 78 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.01e-03 | 21 | 78 | 2 | GO:0030228 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.23e-06 | 92 | 77 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | artery development | 1.05e-05 | 133 | 77 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | lymph circulation | 1.38e-05 | 2 | 77 | 2 | GO:0003017 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 1.39e-05 | 13 | 77 | 3 | GO:0048845 | |
| GeneOntologyBiologicalProcess | humoral immune response | 2.61e-05 | 321 | 77 | 8 | GO:0006959 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 4.12e-05 | 3 | 77 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | SELE EPHB4 SELL IL34 ADORA2B PPARGC1B ANO6 ENPP3 POMC CFP C4BPB CFHR5 PGC SVEP1 NOTCH2 | 4.71e-05 | 1242 | 77 | 15 | GO:0002684 |
| GeneOntologyBiologicalProcess | venous blood vessel development | 5.45e-05 | 20 | 77 | 3 | GO:0060841 | |
| GeneOntologyBiologicalProcess | kidney development | 7.39e-05 | 372 | 77 | 8 | GO:0001822 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 8.21e-05 | 4 | 77 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | renal system development | 9.55e-05 | 386 | 77 | 8 | GO:0072001 | |
| GeneOntologyBiologicalProcess | complement activation | 1.37e-04 | 70 | 77 | 4 | GO:0006956 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.37e-04 | 5 | 77 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor recycling | 1.37e-04 | 5 | 77 | 2 | GO:0001920 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 1.46e-04 | 213 | 77 | 6 | GO:0045807 | |
| GeneOntologyBiologicalProcess | tube development | EPHB4 TMEM67 HEG1 THSD7A ABCA12 TMEM59L ADGRB3 LRP2 SEMA5A ADGRF5 LDLR NOTCH1 NOTCH2 NOTCH3 ADAMTSL2 | 1.83e-04 | 1402 | 77 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 1.89e-04 | 30 | 77 | 3 | GO:0072012 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 1.92e-04 | 320 | 77 | 7 | GO:0002274 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 2.04e-04 | 6 | 77 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 2.04e-04 | 6 | 77 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 2.04e-04 | 6 | 77 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 2.04e-04 | 6 | 77 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 2.04e-04 | 6 | 77 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 2.09e-04 | 31 | 77 | 3 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 2.09e-04 | 31 | 77 | 3 | GO:0061437 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | EPHB4 HEG1 THSD7A ADGRB3 LRP2 SEMA5A ADGRF5 LDLR NOTCH1 NOTCH2 NOTCH3 | 2.16e-04 | 817 | 77 | 11 | GO:0048514 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | JAG2 EPHB4 PAPPA2 TMEM67 PPARGC1B HEG1 TENM3 ABCA12 WNT8B TMEM59L LRP2 LRP4 NOTCH1 NOTCH2 | 2.26e-04 | 1269 | 77 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | vasculature development | EPHB4 HEG1 THSD7A ADGRB3 LRP2 SEMA5A ADGRF5 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 2.37e-04 | 969 | 77 | 12 | GO:0001944 |
| GeneOntologyBiologicalProcess | endocytosis | 2.40e-04 | 827 | 77 | 11 | GO:0006897 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | EPHB4 TMEM67 HEG1 THSD7A TMEM59L ADGRB3 LRP2 SEMA5A ADGRF5 LDLR NOTCH1 NOTCH2 NOTCH3 | 2.49e-04 | 1125 | 77 | 13 | GO:0035239 |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 2.85e-04 | 7 | 77 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 2.85e-04 | 7 | 77 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 2.85e-04 | 7 | 77 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 3.00e-04 | 35 | 77 | 3 | GO:0003209 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 3.80e-04 | 8 | 77 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 3.80e-04 | 8 | 77 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 4.47e-04 | 40 | 77 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 4.87e-04 | 9 | 77 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 4.87e-04 | 9 | 77 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 5.17e-04 | 42 | 77 | 3 | GO:0003230 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 6.07e-04 | 10 | 77 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 6.07e-04 | 10 | 77 | 2 | GO:0030450 | |
| GeneOntologyBiologicalProcess | blood vessel development | EPHB4 HEG1 THSD7A ADGRB3 LRP2 SEMA5A ADGRF5 LDLR NOTCH1 NOTCH2 NOTCH3 | 6.41e-04 | 929 | 77 | 11 | GO:0001568 |
| GeneOntologyBiologicalProcess | axon guidance | 6.88e-04 | 285 | 77 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 7.01e-04 | 286 | 77 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 7.40e-04 | 11 | 77 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | regulation of opsonization | 7.40e-04 | 11 | 77 | 2 | GO:1903027 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis involved in cholesterol transport | 7.40e-04 | 11 | 77 | 2 | GO:0090118 | |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB4 EEF1AKMT4-ECE2 TMEM67 HEG1 THSD7A ADGRB3 LRP2 SEMA5A ADGRF5 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 8.17e-04 | 1442 | 77 | 14 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 8.86e-04 | 12 | 77 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 8.86e-04 | 12 | 77 | 2 | GO:0002924 | |
| GeneOntologyBiologicalProcess | intracellular lipid transport | 1.02e-03 | 53 | 77 | 3 | GO:0032365 | |
| GeneOntologyBiologicalProcess | regulation of intracellular lipid transport | 1.04e-03 | 13 | 77 | 2 | GO:0032377 | |
| GeneOntologyBiologicalProcess | lipid homeostasis | 1.16e-03 | 211 | 77 | 5 | GO:0055088 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.22e-03 | 14 | 77 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 1.22e-03 | 14 | 77 | 2 | GO:0045916 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 1.22e-03 | 14 | 77 | 2 | GO:0070986 | |
| GeneOntologyCellularComponent | cell surface | SELE SELL BOC ADORA2B HEG1 ADAM21 ANO6 CD163L1 ASGR2 ENPP3 ADAMTS15 LRP2 LRP4 ADGRF5 TNFRSF10C CLEC10A LDLR NOTCH1 CD163 NOTCH2 NOTCH3 PCSK9 | 8.00e-11 | 1111 | 79 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | SELE SELL HEG1 ADAM21 CD163L1 ASGR2 ENPP3 LRP2 TNFRSF10C CLEC10A LDLR CD163 PCSK9 | 6.94e-08 | 519 | 79 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | keratin filament | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 8.21e-08 | 97 | 79 | 7 | GO:0045095 |
| GeneOntologyCellularComponent | side of membrane | SELE SELL HEG1 ADAM21 CD163L1 ASGR2 ENPP3 LRP2 CFP TNFRSF10C CLEC10A LDLR CD163 PCSK9 | 4.51e-06 | 875 | 79 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | PCSK9-LDLR complex | 1.41e-05 | 2 | 79 | 2 | GO:1990666 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 2.42e-05 | 227 | 79 | 7 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 6.17e-05 | 263 | 79 | 7 | GO:0045111 |
| HumanPheno | Aortic valve stenosis | 1.35e-06 | 113 | 27 | 7 | HP:0001650 | |
| HumanPheno | Abnormal mitral valve physiology | 2.98e-05 | 180 | 27 | 7 | HP:0031481 | |
| HumanPheno | Abnormal mitral valve morphology | 3.62e-05 | 257 | 27 | 8 | HP:0001633 | |
| HumanPheno | Abnormal aortic valve physiology | 4.53e-05 | 192 | 27 | 7 | HP:0031652 | |
| HumanPheno | Abnormal aortic valve morphology | 8.38e-05 | 289 | 27 | 8 | HP:0001646 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 9.33e-05 | 215 | 27 | 7 | HP:0031650 | |
| HumanPheno | Abnormal heart valve morphology | ADAMTS15 LRP4 MUC5B LTBP2 CBL LDLR NOTCH1 NOTCH2 NOTCH3 ADAMTSL2 PCSK9 | 1.01e-04 | 588 | 27 | 11 | HP:0001654 |
| HumanPheno | Abnormal heart valve physiology | 1.44e-04 | 403 | 27 | 9 | HP:0031653 | |
| HumanPheno | Calcification of the aorta | 2.19e-04 | 23 | 27 | 3 | HP:0004963 | |
| MousePheno | increased circulating interleukin level | 7.10e-05 | 170 | 58 | 6 | MP:0014497 | |
| MousePheno | increased circulating interleukin-6 level | 7.26e-05 | 105 | 58 | 5 | MP:0008596 | |
| MousePheno | increased interleukin level | 8.08e-05 | 174 | 58 | 6 | MP:0014437 | |
| MousePheno | thick apical ectodermal ridge | 1.01e-04 | 4 | 58 | 2 | MP:0001678 | |
| MousePheno | abnormal femur compact bone thickness | 1.13e-04 | 23 | 58 | 3 | MP:0013622 | |
| MousePheno | increased circulating cytokine level | 1.39e-04 | 192 | 58 | 6 | MP:0014493 | |
| Domain | EGF-like_dom | SELE JAG2 SELL EYS HEG1 FCGBP MALRD1 TENM3 ADAM21 LRP2 LRP4 LTBP2 NAGPA LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 6.01e-18 | 249 | 76 | 18 | IPR000742 |
| Domain | EGF-like_CS | SELE JAG2 EPHB4 SELL EYS HEG1 MALRD1 TENM3 ADAM21 LRP2 LRP4 LTBP2 NAGPA LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 1.39e-17 | 261 | 76 | 18 | IPR013032 |
| Domain | EGF_2 | SELE JAG2 EPHB4 SELL EYS HEG1 MALRD1 TENM3 ADAM21 LRP2 LRP4 LTBP2 NAGPA LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 1.83e-17 | 265 | 76 | 18 | PS01186 |
| Domain | EGF_3 | SELE JAG2 SELL EYS HEG1 MALRD1 TENM3 ADAM21 LRP2 LRP4 LTBP2 NAGPA LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 5.49e-17 | 235 | 76 | 17 | PS50026 |
| Domain | EGF | SELE JAG2 SELL EYS HEG1 FCGBP MALRD1 TENM3 LRP2 LRP4 LTBP2 NAGPA LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 5.49e-17 | 235 | 76 | 17 | SM00181 |
| Domain | EGF | SELE JAG2 SELL EYS HEG1 MALRD1 LRP2 LRP4 LTBP2 NAGPA SVEP1 NOTCH1 NOTCH2 NOTCH3 | 9.32e-17 | 126 | 76 | 14 | PF00008 |
| Domain | EGF_1 | SELE JAG2 SELL EYS HEG1 MALRD1 TENM3 ADAM21 LRP2 LRP4 LTBP2 NAGPA LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 2.17e-16 | 255 | 76 | 17 | PS00022 |
| Domain | EGF_Ca-bd_CS | JAG2 EYS HEG1 LRP2 LRP4 LTBP2 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 1.80e-13 | 97 | 76 | 11 | IPR018097 |
| Domain | EGF_CA | JAG2 EYS HEG1 LRP2 LRP4 LTBP2 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 2.26e-13 | 99 | 76 | 11 | PS01187 |
| Domain | ASX_HYDROXYL | JAG2 EYS HEG1 LRP2 LRP4 LTBP2 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 2.53e-13 | 100 | 76 | 11 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | JAG2 EYS HEG1 LRP2 LRP4 LTBP2 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 4.87e-13 | 106 | 76 | 11 | IPR000152 |
| Domain | Growth_fac_rcpt_ | JAG2 EPHB4 TMEM67 EYS LRP2 LRP4 LTBP2 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 1.47e-12 | 156 | 76 | 12 | IPR009030 |
| Domain | EGF_CA | 1.86e-12 | 86 | 76 | 10 | PF07645 | |
| Domain | EGF_CA | JAG2 EYS HEG1 LRP2 LRP4 LTBP2 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 2.34e-12 | 122 | 76 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | JAG2 EYS HEG1 LRP2 LRP4 LTBP2 LDLR SVEP1 NOTCH1 NOTCH2 NOTCH3 | 2.80e-12 | 124 | 76 | 11 | IPR001881 |
| Domain | Notch_dom | 2.04e-11 | 7 | 76 | 5 | IPR000800 | |
| Domain | Notch | 2.04e-11 | 7 | 76 | 5 | PF00066 | |
| Domain | NL | 2.04e-11 | 7 | 76 | 5 | SM00004 | |
| Domain | Sushi | 3.36e-11 | 52 | 76 | 8 | PF00084 | |
| Domain | CCP | 4.61e-11 | 54 | 76 | 8 | SM00032 | |
| Domain | SUSHI | 6.25e-11 | 56 | 76 | 8 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 7.25e-11 | 57 | 76 | 8 | IPR000436 | |
| Domain | EGF_extracell | 1.11e-10 | 60 | 76 | 8 | IPR013111 | |
| Domain | EGF_2 | 1.11e-10 | 60 | 76 | 8 | PF07974 | |
| Domain | Aamy_C | 2.53e-10 | 4 | 76 | 4 | SM00632 | |
| Domain | Alpha_amylase | 2.53e-10 | 4 | 76 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 1.26e-09 | 5 | 76 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 1.26e-09 | 5 | 76 | 4 | IPR006048 | |
| Domain | hEGF | 1.30e-09 | 28 | 76 | 6 | PF12661 | |
| Domain | KAP | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 3.55e-09 | 58 | 76 | 7 | IPR002494 |
| Domain | Aamy | 8.78e-09 | 7 | 76 | 4 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 8.78e-09 | 7 | 76 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 8.78e-09 | 7 | 76 | 4 | PF00128 | |
| Domain | DUF3454 | 6.48e-08 | 3 | 76 | 3 | PF11936 | |
| Domain | DUF3454_notch | 6.48e-08 | 3 | 76 | 3 | IPR024600 | |
| Domain | A-amylase_C | 6.48e-08 | 3 | 76 | 3 | IPR031319 | |
| Domain | DUF3454 | 6.48e-08 | 3 | 76 | 3 | SM01334 | |
| Domain | TSP_1 | 2.10e-07 | 63 | 76 | 6 | PF00090 | |
| Domain | TSP1 | 2.54e-07 | 65 | 76 | 6 | SM00209 | |
| Domain | TSP1_rpt | 2.54e-07 | 65 | 76 | 6 | IPR000884 | |
| Domain | TSP1 | 2.54e-07 | 65 | 76 | 6 | PS50092 | |
| Domain | Notch | 2.58e-07 | 4 | 76 | 3 | IPR008297 | |
| Domain | NODP | 2.58e-07 | 4 | 76 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 2.58e-07 | 4 | 76 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.58e-07 | 4 | 76 | 3 | IPR010660 | |
| Domain | NOD | 2.58e-07 | 4 | 76 | 3 | PF06816 | |
| Domain | NOD | 2.58e-07 | 4 | 76 | 3 | SM01338 | |
| Domain | NODP | 2.58e-07 | 4 | 76 | 3 | SM01339 | |
| Domain | Glyco_hydro_b | 3.34e-07 | 15 | 76 | 4 | IPR013780 | |
| Domain | Keratin_B2_2 | 5.05e-07 | 39 | 76 | 5 | PF13885 | |
| Domain | Keratin_B2 | 5.75e-07 | 40 | 76 | 5 | PF01500 | |
| Domain | LNR | 6.44e-07 | 5 | 76 | 3 | PS50258 | |
| Domain | Glyco_hydro_13 | 1.28e-06 | 6 | 76 | 3 | IPR015902 | |
| Domain | Peptidase_M43 | 1.63e-05 | 2 | 76 | 2 | IPR008754 | |
| Domain | Peptidase_M43 | 1.63e-05 | 2 | 76 | 2 | PF05572 | |
| Domain | Glyco_hydro_catalytic_dom | 1.68e-05 | 38 | 76 | 4 | IPR013781 | |
| Domain | - | 1.87e-05 | 39 | 76 | 4 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 2.07e-05 | 40 | 76 | 4 | IPR023415 | |
| Domain | - | 2.28e-05 | 14 | 76 | 3 | 2.60.40.1180 | |
| Domain | TIL_dom | 2.28e-05 | 14 | 76 | 3 | IPR002919 | |
| Domain | Ldl_recept_b | 2.28e-05 | 14 | 76 | 3 | PF00058 | |
| Domain | LDLRB | 2.28e-05 | 14 | 76 | 3 | PS51120 | |
| Domain | C-type_lectin_CS | 2.77e-05 | 43 | 76 | 4 | IPR018378 | |
| Domain | LY | 2.84e-05 | 15 | 76 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.84e-05 | 15 | 76 | 3 | IPR000033 | |
| Domain | Ldl_recept_a | 3.32e-05 | 45 | 76 | 4 | PF00057 | |
| Domain | - | 3.63e-05 | 46 | 76 | 4 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.63e-05 | 46 | 76 | 4 | IPR011042 | |
| Domain | LDLRA_1 | 4.30e-05 | 48 | 76 | 4 | PS01209 | |
| Domain | LDLRA_2 | 4.67e-05 | 49 | 76 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 4.67e-05 | 49 | 76 | 4 | IPR002172 | |
| Domain | LDLa | 4.67e-05 | 49 | 76 | 4 | SM00192 | |
| Domain | Lectin_N | 4.89e-05 | 3 | 76 | 2 | PF03954 | |
| Domain | Myxo_disulph_rpt | 4.89e-05 | 3 | 76 | 2 | IPR011936 | |
| Domain | Selectin_superfamily | 4.89e-05 | 3 | 76 | 2 | IPR002396 | |
| Domain | Lectin_N | 4.89e-05 | 3 | 76 | 2 | IPR005640 | |
| Domain | VWC_out | 5.99e-05 | 19 | 76 | 3 | SM00215 | |
| Domain | Glycoside_hydrolase_SF | 6.37e-05 | 53 | 76 | 4 | IPR017853 | |
| Domain | LamGL | 9.75e-05 | 4 | 76 | 2 | SM00560 | |
| Domain | LamG-like | 9.75e-05 | 4 | 76 | 2 | IPR006558 | |
| Domain | ConA-like_dom | 2.68e-04 | 219 | 76 | 6 | IPR013320 | |
| Domain | C_TYPE_LECTIN_1 | 3.17e-04 | 80 | 76 | 4 | PS00615 | |
| Domain | MetalloPept_cat_dom | 3.32e-04 | 81 | 76 | 4 | IPR024079 | |
| Domain | - | 3.32e-04 | 81 | 76 | 4 | 3.40.390.10 | |
| Domain | Hirudin/antistatin | 3.39e-04 | 7 | 76 | 2 | IPR011061 | |
| Domain | Lectin_C | 3.82e-04 | 84 | 76 | 4 | PF00059 | |
| Domain | CLECT | 3.82e-04 | 84 | 76 | 4 | SM00034 | |
| Domain | - | 3.86e-04 | 35 | 76 | 3 | 3.20.20.80 | |
| Domain | C_TYPE_LECTIN_2 | 3.99e-04 | 85 | 76 | 4 | PS50041 | |
| Domain | C-type_lectin-like | 4.18e-04 | 86 | 76 | 4 | IPR001304 | |
| Domain | VWC | 4.93e-04 | 38 | 76 | 3 | SM00214 | |
| Domain | - | 6.09e-04 | 95 | 76 | 4 | 2.60.120.200 | |
| Domain | - | 6.59e-04 | 97 | 76 | 4 | 3.10.100.10 | |
| Domain | VWF_dom | 6.63e-04 | 42 | 76 | 3 | IPR001007 | |
| Domain | ZINC_PROTEASE | 6.85e-04 | 98 | 76 | 4 | PS00142 | |
| Domain | C-type_lectin-like/link | 7.11e-04 | 99 | 76 | 4 | IPR016186 | |
| Domain | Ephrin_rec_like | 8.78e-04 | 11 | 76 | 2 | PF07699 | |
| Domain | CTDL_fold | 9.52e-04 | 107 | 76 | 4 | IPR016187 | |
| Domain | TIL | 1.05e-03 | 12 | 76 | 2 | PF01826 | |
| Domain | C8 | 1.05e-03 | 12 | 76 | 2 | PF08742 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | THSD7A ADAMTS15 SEMA5A CFP MUC5B NOTCH1 NOTCH2 NOTCH3 ADAMTSL2 | 2.11e-11 | 68 | 65 | 9 | M27303 |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 2.21e-10 | 9 | 65 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 8.06e-10 | 11 | 65 | 5 | M1091 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | THSD7A ADAMTS15 SEMA5A CFP MUC5B NOTCH1 NOTCH2 NOTCH3 ADAMTSL2 | 1.74e-08 | 143 | 65 | 9 | M27275 |
| Pathway | REACTOME_DIGESTION | 5.62e-08 | 23 | 65 | 5 | M27790 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.31e-07 | 52 | 65 | 6 | M14171 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.61e-07 | 28 | 65 | 5 | M27837 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THSD7A ADAMTS15 POMC SEMA5A CFP MUC5B NOTCH1 NOTCH2 NOTCH3 ADAMTSL2 | 1.95e-07 | 250 | 65 | 10 | M27554 |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.85e-07 | 13 | 65 | 4 | M47423 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.09e-07 | 39 | 65 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.09e-07 | 39 | 65 | 5 | MM15165 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 9.30e-07 | 5 | 65 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.85e-06 | 6 | 65 | 3 | M27068 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 5.15e-06 | 8 | 65 | 3 | MM14717 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 6.67e-06 | 27 | 65 | 4 | M39545 | |
| Pathway | PID_NOTCH_PATHWAY | 7.36e-06 | 59 | 65 | 5 | M17 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.06e-05 | 109 | 65 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.18e-05 | 111 | 65 | 6 | M27416 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.50e-05 | 11 | 65 | 3 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.00e-05 | 12 | 65 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.00e-05 | 12 | 65 | 3 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.59e-05 | 13 | 65 | 3 | M47534 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 5.32e-05 | 45 | 65 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 5.81e-05 | 46 | 65 | 4 | MM15971 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 6.07e-05 | 217 | 65 | 7 | M27640 |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 6.33e-05 | 47 | 65 | 4 | M7946 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 7.22e-05 | 153 | 65 | 6 | MM15343 |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 7.27e-05 | 18 | 65 | 3 | M614 | |
| Pathway | REACTOME_DIGESTION | 1.17e-04 | 21 | 65 | 3 | MM15526 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.76e-04 | 61 | 65 | 4 | M39540 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.77e-04 | 24 | 65 | 3 | M11190 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.00e-04 | 25 | 65 | 3 | MM15557 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.07e-04 | 5 | 65 | 2 | MM14733 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 2.09e-04 | 118 | 65 | 5 | M39852 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.82e-04 | 28 | 65 | 3 | M6177 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 3.48e-04 | 381 | 65 | 8 | M48063 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 4.33e-04 | 7 | 65 | 2 | M27199 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.33e-04 | 7 | 65 | 2 | MM14734 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 5.06e-04 | 34 | 65 | 3 | M39390 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 5.50e-04 | 82 | 65 | 4 | MM15922 | |
| Pathway | BIOCARTA_NEUTROPHIL_PATHWAY | 5.76e-04 | 8 | 65 | 2 | MM1536 | |
| Pathway | BIOCARTA_NEUTROPHIL_PATHWAY | 5.76e-04 | 8 | 65 | 2 | M22010 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 6.50e-04 | 37 | 65 | 3 | M39506 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 7.38e-04 | 9 | 65 | 2 | MM1534 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR | 7.38e-04 | 9 | 65 | 2 | M47893 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 7.38e-04 | 9 | 65 | 2 | M22008 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 7.59e-04 | 39 | 65 | 3 | MM14604 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 8.68e-04 | 161 | 65 | 5 | M39770 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 9.20e-04 | 10 | 65 | 2 | MM14849 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 9.95e-04 | 96 | 65 | 4 | M39581 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 1.12e-03 | 11 | 65 | 2 | MM1436 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 1.12e-03 | 11 | 65 | 2 | M4956 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.34e-03 | 12 | 65 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.34e-03 | 12 | 65 | 2 | M22042 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.48e-03 | 49 | 65 | 3 | M618 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB4 SEMA5A KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 2.07e-03 | 502 | 65 | 8 | MM14537 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 2.11e-03 | 15 | 65 | 2 | M27202 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 2.27e-03 | 200 | 65 | 5 | M48048 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.41e-03 | 16 | 65 | 2 | M47424 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2 | 2.41e-03 | 16 | 65 | 2 | M42564 | |
| Pathway | WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES | 2.72e-03 | 17 | 65 | 2 | M39747 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.72e-03 | 17 | 65 | 2 | M39389 | |
| Pathway | REACTOME_LDL_CLEARANCE | 3.05e-03 | 18 | 65 | 2 | MM15565 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.05e-03 | 18 | 65 | 2 | MM14775 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.40e-03 | 19 | 65 | 2 | MM15594 | |
| Pathway | REACTOME_LDL_CLEARANCE | 3.40e-03 | 19 | 65 | 2 | M27846 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.77e-03 | 20 | 65 | 2 | M27881 | |
| Pubmed | 6.93e-18 | 16 | 80 | 8 | 10842072 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 2.95e-14 | 21 | 80 | 7 | 14702043 | |
| Pubmed | 3.40e-13 | 6 | 80 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 3.40e-13 | 6 | 80 | 5 | 2788608 | |
| Pubmed | 3.40e-13 | 6 | 80 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 3.40e-13 | 6 | 80 | 5 | 6608795 | |
| Pubmed | 3.40e-13 | 6 | 80 | 5 | 2081604 | ||
| Pubmed | KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 9.62e-13 | 16 | 80 | 6 | 15028290 | |
| Pubmed | 3.16e-12 | 8 | 80 | 5 | 12414807 | ||
| Pubmed | 6.46e-12 | 21 | 80 | 6 | 14651921 | ||
| Pubmed | 2.59e-11 | 11 | 80 | 5 | 14962103 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 2.59e-11 | 4 | 80 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 2.59e-11 | 4 | 80 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 2.59e-11 | 4 | 80 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 2.59e-11 | 4 | 80 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 2.59e-11 | 4 | 80 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 2.59e-11 | 4 | 80 | 4 | 94264 | |
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 3872721 | ||
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 2.59e-11 | 4 | 80 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 2.59e-11 | 4 | 80 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 2.59e-11 | 4 | 80 | 4 | 2987507 | |
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 6091898 | ||
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 2.59e-11 | 4 | 80 | 4 | 6162108 | |
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 16152770 | ||
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 2423416 | ||
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 2.59e-11 | 4 | 80 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 2.59e-11 | 4 | 80 | 4 | 2989529 | |
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 2.59e-11 | 4 | 80 | 4 | 1141004 | |
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 2.59e-11 | 4 | 80 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 2.59e-11 | 4 | 80 | 4 | 6207174 | |
| Pubmed | 2.59e-11 | 4 | 80 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 2.59e-11 | 4 | 80 | 4 | 2332419 | |
| Pubmed | 1.30e-10 | 5 | 80 | 4 | 6529441 | ||
| Pubmed | 1.30e-10 | 5 | 80 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.30e-10 | 5 | 80 | 4 | 34276419 | |
| Pubmed | 1.30e-10 | 5 | 80 | 4 | 1348427 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 1.30e-10 | 5 | 80 | 4 | 15064243 | |
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.30e-10 | 5 | 80 | 4 | 8661735 | |
| Pubmed | 3.88e-10 | 6 | 80 | 4 | 2002257 | ||
| Pubmed | 3.88e-10 | 6 | 80 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 3.88e-10 | 6 | 80 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 3.88e-10 | 6 | 80 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 3.88e-10 | 6 | 80 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 3.88e-10 | 6 | 80 | 4 | 7859283 | |
| Pubmed | 3.88e-10 | 6 | 80 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 3.88e-10 | 6 | 80 | 4 | 1021597 | |
| Pubmed | 4.75e-10 | 18 | 80 | 5 | 18093989 | ||
| Pubmed | 9.03e-10 | 7 | 80 | 4 | 10383933 | ||
| Pubmed | 9.03e-10 | 7 | 80 | 4 | 10079256 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 9.03e-10 | 7 | 80 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 9.03e-10 | 7 | 80 | 4 | 2451911 | |
| Pubmed | 9.03e-10 | 7 | 80 | 4 | 7949740 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 9.03e-10 | 7 | 80 | 4 | 12846471 | |
| Pubmed | 9.03e-10 | 7 | 80 | 4 | 6160178 | ||
| Pubmed | 9.03e-10 | 7 | 80 | 4 | 8604219 | ||
| Pubmed | 9.03e-10 | 7 | 80 | 4 | 8666240 | ||
| Pubmed | 9.03e-10 | 7 | 80 | 4 | 16169548 | ||
| Pubmed | 1.80e-09 | 8 | 80 | 4 | 2040456 | ||
| Pubmed | 1.80e-09 | 8 | 80 | 4 | 3038891 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.80e-09 | 8 | 80 | 4 | 22652674 | |
| Pubmed | 1.80e-09 | 8 | 80 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 1.80e-09 | 8 | 80 | 4 | 7523515 | |
| Pubmed | 1.80e-09 | 8 | 80 | 4 | 9858718 | ||
| Pubmed | 1.80e-09 | 8 | 80 | 4 | 11044610 | ||
| Pubmed | 1.80e-09 | 8 | 80 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 1.80e-09 | 8 | 80 | 4 | 6200103 | |
| Pubmed | 3.24e-09 | 9 | 80 | 4 | 93520 | ||
| Pubmed | 3.24e-09 | 9 | 80 | 4 | 11118901 | ||
| Pubmed | 3.24e-09 | 9 | 80 | 4 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 5.39e-09 | 10 | 80 | 4 | 23665443 | |
| Pubmed | 5.39e-09 | 10 | 80 | 4 | 9121556 | ||
| Pubmed | 5.39e-09 | 10 | 80 | 4 | 15280211 | ||
| Pubmed | 5.39e-09 | 10 | 80 | 4 | 2897103 | ||
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 23449223 | ||
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 7608209 | ||
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 1617215 | ||
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 2903254 | ||
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 8.46e-09 | 11 | 80 | 4 | 16607638 | |
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 2565740 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 8.46e-09 | 11 | 80 | 4 | 7493641 | |
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 10878608 | ||
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 8.46e-09 | 11 | 80 | 4 | 8589528 | |
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 12866128 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.17e-08 | 3 | 80 | 3 | 2413838 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 8645602 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary Îą-amylase: a behavioral genetic study. | 1.17e-08 | 3 | 80 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.17e-08 | 3 | 80 | 3 | 6360562 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 27697639 | ||
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.17e-08 | 3 | 80 | 3 | 2436036 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.17e-08 | 3 | 80 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.17e-08 | 3 | 80 | 3 | 17223109 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 15299664 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 8413315 | ||
| Interaction | NTN5 interactions | 2.95e-12 | 24 | 77 | 7 | int:NTN5 | |
| Interaction | IGFL3 interactions | 4.29e-10 | 75 | 77 | 8 | int:IGFL3 | |
| Interaction | IGSF5 interactions | 1.39e-09 | 14 | 77 | 5 | int:IGSF5 | |
| Interaction | ZNF74 interactions | 3.15e-09 | 34 | 77 | 6 | int:ZNF74 | |
| Interaction | ZFP41 interactions | 7.93e-08 | 57 | 77 | 6 | int:ZFP41 | |
| Interaction | LGALS1 interactions | JAG2 HEG1 TENM3 LRP2 TNFRSF10C NAGPA LDLR NOTCH1 NOTCH2 NOTCH3 | 5.31e-07 | 332 | 77 | 10 | int:LGALS1 |
| Interaction | ZNF707 interactions | 5.68e-07 | 79 | 77 | 6 | int:ZNF707 | |
| Interaction | HOXA1 interactions | JAG2 CFP KRTAP26-1 KRTAP10-1 NOTCH1 CD163 KRTAP10-4 KRTAP10-7 NOTCH3 ADAMTSL2 | 1.00e-06 | 356 | 77 | 10 | int:HOXA1 |
| Interaction | TIMP3 interactions | 1.23e-06 | 90 | 77 | 6 | int:TIMP3 | |
| Interaction | ST14 interactions | 1.24e-06 | 207 | 77 | 8 | int:ST14 | |
| Interaction | ZNF408 interactions | 1.36e-06 | 145 | 77 | 7 | int:ZNF408 | |
| Interaction | PRG2 interactions | 1.39e-06 | 285 | 77 | 9 | int:PRG2 | |
| Interaction | RSPO2 interactions | 1.97e-06 | 24 | 77 | 4 | int:RSPO2 | |
| Interaction | ZSCAN26 interactions | 3.04e-06 | 59 | 77 | 5 | int:ZSCAN26 | |
| Interaction | FBXO2 interactions | 3.62e-06 | 411 | 77 | 10 | int:FBXO2 | |
| Interaction | ZNF480 interactions | 4.43e-06 | 9 | 77 | 3 | int:ZNF480 | |
| Interaction | ZNF696 interactions | 6.17e-06 | 68 | 77 | 5 | int:ZNF696 | |
| Interaction | AMY2B interactions | 6.31e-06 | 10 | 77 | 3 | int:AMY2B | |
| Interaction | ZNF778 interactions | 8.66e-06 | 11 | 77 | 3 | int:ZNF778 | |
| Interaction | DLK2 interactions | 1.06e-05 | 36 | 77 | 4 | int:DLK2 | |
| Interaction | EGFL7 interactions | 1.14e-05 | 77 | 77 | 5 | int:EGFL7 | |
| Interaction | ZNF555 interactions | 1.15e-05 | 12 | 77 | 3 | int:ZNF555 | |
| Interaction | JAG1 interactions | 1.79e-05 | 41 | 77 | 4 | int:JAG1 | |
| Interaction | ZNF264 interactions | 1.79e-05 | 41 | 77 | 4 | int:ZNF264 | |
| Interaction | ZNF625 interactions | 2.36e-05 | 15 | 77 | 3 | int:ZNF625 | |
| Interaction | DEFB123 interactions | 2.90e-05 | 16 | 77 | 3 | int:DEFB123 | |
| Interaction | ZNF260 interactions | 2.90e-05 | 16 | 77 | 3 | int:ZNF260 | |
| Interaction | ZNF32 interactions | 2.90e-05 | 16 | 77 | 3 | int:ZNF32 | |
| Interaction | AVPI1 interactions | 3.37e-05 | 48 | 77 | 4 | int:AVPI1 | |
| Interaction | MAML2 interactions | 3.51e-05 | 17 | 77 | 3 | int:MAML2 | |
| Interaction | WNT3A interactions | 3.66e-05 | 49 | 77 | 4 | int:WNT3A | |
| Interaction | FOXD4L6 interactions | 3.66e-05 | 49 | 77 | 4 | int:FOXD4L6 | |
| Interaction | ZNF490 interactions | 3.97e-05 | 50 | 77 | 4 | int:ZNF490 | |
| Interaction | ZNF138 interactions | 4.97e-05 | 19 | 77 | 3 | int:ZNF138 | |
| Interaction | CCN6 interactions | 4.97e-05 | 19 | 77 | 3 | int:CCN6 | |
| Interaction | ZNF224 interactions | 5.83e-05 | 20 | 77 | 3 | int:ZNF224 | |
| Interaction | MAML3 interactions | 5.83e-05 | 20 | 77 | 3 | int:MAML3 | |
| Interaction | EDN3 interactions | 5.85e-05 | 108 | 77 | 5 | int:EDN3 | |
| Interaction | NKD1 interactions | 6.79e-05 | 21 | 77 | 3 | int:NKD1 | |
| Interaction | LYPD1 interactions | 7.15e-05 | 58 | 77 | 4 | int:LYPD1 | |
| Interaction | NOTCH3 interactions | 7.26e-05 | 113 | 77 | 5 | int:NOTCH3 | |
| Interaction | CASR interactions | 7.84e-05 | 22 | 77 | 3 | int:CASR | |
| Interaction | MOBP interactions | 8.99e-05 | 23 | 77 | 3 | int:MOBP | |
| Interaction | BRICD5 interactions | 9.90e-05 | 194 | 77 | 6 | int:BRICD5 | |
| Interaction | ZNF765 interactions | 1.02e-04 | 24 | 77 | 3 | int:ZNF765 | |
| Interaction | SPATA3 interactions | 1.02e-04 | 24 | 77 | 3 | int:SPATA3 | |
| Interaction | ZNF320 interactions | 1.47e-04 | 27 | 77 | 3 | int:ZNF320 | |
| Interaction | MARCHF1 interactions | 1.49e-04 | 70 | 77 | 4 | int:MARCHF1 | |
| Interaction | P2RX2 interactions | 1.49e-04 | 70 | 77 | 4 | int:P2RX2 | |
| Interaction | FEZF1 interactions | 1.64e-04 | 28 | 77 | 3 | int:FEZF1 | |
| Interaction | MAPKBP1 interactions | 1.85e-04 | 74 | 77 | 4 | int:MAPKBP1 | |
| Interaction | HTN3 interactions | 2.02e-04 | 30 | 77 | 3 | int:HTN3 | |
| Interaction | WT1 interactions | 2.05e-04 | 76 | 77 | 4 | int:WT1 | |
| Interaction | ZNF107 interactions | 2.23e-04 | 31 | 77 | 3 | int:ZNF107 | |
| Interaction | ZNF664 interactions | 2.23e-04 | 31 | 77 | 3 | int:ZNF664 | |
| Interaction | ZBBX interactions | 2.23e-04 | 31 | 77 | 3 | int:ZBBX | |
| Interaction | CLEC2B interactions | 2.50e-04 | 147 | 77 | 5 | int:CLEC2B | |
| Interaction | KRTAP4-4 interactions | 2.62e-04 | 81 | 77 | 4 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 2.62e-04 | 81 | 77 | 4 | int:LCE2B | |
| Interaction | MSTN interactions | 2.69e-04 | 33 | 77 | 3 | int:MSTN | |
| Interaction | ZNF101 interactions | 2.69e-04 | 33 | 77 | 3 | int:ZNF101 | |
| Interaction | ZNF594 interactions | 2.99e-04 | 7 | 77 | 2 | int:ZNF594 | |
| Interaction | LCE1A interactions | 3.02e-04 | 84 | 77 | 4 | int:LCE1A | |
| Interaction | ZBTB24 interactions | 3.59e-04 | 159 | 77 | 5 | int:ZBTB24 | |
| Interaction | VASN interactions | 3.69e-04 | 160 | 77 | 5 | int:VASN | |
| Interaction | CXCL16 interactions | 3.76e-04 | 89 | 77 | 4 | int:CXCL16 | |
| Interaction | WNT10A interactions | 3.79e-04 | 37 | 77 | 3 | int:WNT10A | |
| Interaction | GREM2 interactions | 3.79e-04 | 37 | 77 | 3 | int:GREM2 | |
| Interaction | ZNF621 interactions | 3.97e-04 | 8 | 77 | 2 | int:ZNF621 | |
| Interaction | DLL1 interactions | 4.11e-04 | 38 | 77 | 3 | int:DLL1 | |
| Interaction | ZNF624 interactions | 4.11e-04 | 38 | 77 | 3 | int:ZNF624 | |
| Interaction | ELSPBP1 interactions | 4.27e-04 | 92 | 77 | 4 | int:ELSPBP1 | |
| Interaction | LCE1F interactions | 4.27e-04 | 92 | 77 | 4 | int:LCE1F | |
| Interaction | KRTAP26-1 interactions | 4.63e-04 | 94 | 77 | 4 | int:KRTAP26-1 | |
| Interaction | KRTAP5-6 interactions | 4.63e-04 | 94 | 77 | 4 | int:KRTAP5-6 | |
| Interaction | ZNF440 interactions | 4.79e-04 | 40 | 77 | 3 | int:ZNF440 | |
| Interaction | ZNF761 interactions | 5.10e-04 | 9 | 77 | 2 | int:ZNF761 | |
| Interaction | ZNF419 interactions | 5.10e-04 | 9 | 77 | 2 | int:ZNF419 | |
| Interaction | ZKSCAN2 interactions | 5.10e-04 | 9 | 77 | 2 | int:ZKSCAN2 | |
| Interaction | IGFBP4 interactions | 5.15e-04 | 41 | 77 | 3 | int:IGFBP4 | |
| Interaction | KRTAP9-8 interactions | 5.85e-04 | 100 | 77 | 4 | int:KRTAP9-8 | |
| Interaction | LRRIQ1 interactions | 5.93e-04 | 43 | 77 | 3 | int:LRRIQ1 | |
| Interaction | ZNF398 interactions | 5.93e-04 | 43 | 77 | 3 | int:ZNF398 | |
| Interaction | ZNF417 interactions | 6.01e-04 | 178 | 77 | 5 | int:ZNF417 | |
| Interaction | E4F1 interactions | 6.08e-04 | 101 | 77 | 4 | int:E4F1 | |
| Interaction | DEFB136 interactions | 6.35e-04 | 44 | 77 | 3 | int:DEFB136 | |
| Interaction | ZNF766 interactions | 6.36e-04 | 10 | 77 | 2 | int:ZNF766 | |
| Interaction | ZNF433 interactions | 6.36e-04 | 10 | 77 | 2 | int:ZNF433 | |
| Interaction | LCE3B interactions | 7.23e-04 | 46 | 77 | 3 | int:LCE3B | |
| Interaction | ZNF865 interactions | 7.71e-04 | 47 | 77 | 3 | int:ZNF865 | |
| Interaction | AEN interactions | 7.71e-04 | 47 | 77 | 3 | int:AEN | |
| Interaction | TAFA2 interactions | 7.71e-04 | 47 | 77 | 3 | int:TAFA2 | |
| Interaction | ZNF155 interactions | 7.75e-04 | 11 | 77 | 2 | int:ZNF155 | |
| Interaction | POM121L8P interactions | 7.75e-04 | 11 | 77 | 2 | int:POM121L8P | |
| Interaction | ANKRD44 interactions | 8.20e-04 | 48 | 77 | 3 | int:ANKRD44 | |
| Interaction | JAG2 interactions | 8.37e-04 | 110 | 77 | 4 | int:JAG2 | |
| Interaction | PRG3 interactions | 8.71e-04 | 49 | 77 | 3 | int:PRG3 | |
| Interaction | PATE1 interactions | 8.71e-04 | 49 | 77 | 3 | int:PATE1 | |
| Interaction | DKK2 interactions | 8.71e-04 | 49 | 77 | 3 | int:DKK2 | |
| Interaction | ADAMTS15 interactions | 9.28e-04 | 12 | 77 | 2 | int:ADAMTS15 | |
| Cytoband | 1p21 | 5.86e-10 | 24 | 80 | 5 | 1p21 | |
| Cytoband | 21q22.3 | KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 1.06e-07 | 128 | 80 | 6 | 21q22.3 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.31e-06 | 107 | 80 | 5 | chr1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 4.52e-06 | 377 | 80 | 7 | chr21q22 |
| Cytoband | 1q23-q25 | 1.80e-05 | 4 | 80 | 2 | 1q23-q25 | |
| Cytoband | 6q12 | 6.77e-04 | 22 | 80 | 2 | 6q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q12 | 9.48e-04 | 26 | 80 | 2 | chr6q12 | |
| Cytoband | 12p13.3 | 1.26e-03 | 30 | 80 | 2 | 12p13.3 | |
| Cytoband | 9q32 | 3.08e-03 | 47 | 80 | 2 | 9q32 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.44e-12 | 57 | 54 | 8 | 1179 | |
| GeneFamily | Keratin associated proteins | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 3.34e-08 | 109 | 54 | 7 | 619 |
| GeneFamily | Low density lipoprotein receptors | 7.05e-06 | 13 | 54 | 3 | 634 | |
| GeneFamily | Pappalysins|Sushi domain containing | 8.76e-06 | 2 | 54 | 2 | 897 | |
| GeneFamily | CD molecules|Selectins|Sushi domain containing|C-type lectin domain containing | 2.62e-05 | 3 | 54 | 2 | 945 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.10e-03 | 394 | 54 | 6 | 471 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.93e-03 | 27 | 54 | 2 | 1253 | |
| GeneFamily | Complement system|Sushi domain containing | 5.17e-03 | 36 | 54 | 2 | 492 | |
| GeneFamily | Ankyrin repeat domain containing | 5.86e-03 | 242 | 54 | 4 | 403 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.66e-03 | 41 | 54 | 2 | 1298 | |
| GeneFamily | C-type lectin domain family | 8.69e-03 | 47 | 54 | 2 | 494 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.29e-07 | 16 | 78 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.29e-07 | 16 | 78 | 4 | M2207 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 2.78e-06 | 132 | 78 | 6 | MM470 | |
| Coexpression | BERGER_MBD2_TARGETS | 4.11e-06 | 11 | 78 | 3 | MM905 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 6.76e-06 | 41 | 78 | 4 | MM698 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 7.31e-06 | 239 | 78 | 7 | MM1274 | |
| Coexpression | NABA_MATRISOME | IL34 PAPPA2 EYS ADAM21 WNT8B ADAMTS15 PAPPA SEMA5A MUC5B LTBP2 CLEC10A SVEP1 ADAMTSL2 | 9.77e-06 | 1026 | 78 | 13 | M5889 |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.07e-05 | 97 | 78 | 5 | MM1016 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 2.54e-05 | 116 | 78 | 5 | MM1240 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 2.98e-05 | 200 | 78 | 6 | M3584 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_DN | 2.98e-05 | 200 | 78 | 6 | M3082 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 3.12e-05 | 60 | 78 | 4 | MM654 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 3.50e-05 | 124 | 78 | 5 | M45686 | |
| Coexpression | NABA_MATRISOME | IL34 PAPPA2 ADAM21 WNT8B ADAMTS15 PAPPA SEMA5A MUC5B LTBP2 CLEC10A SVEP1 ADAMTSL2 | 4.10e-05 | 1008 | 78 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | IL34 PAPPA2 ADAM21 WNT8B ADAMTS15 PAPPA SEMA5A MUC5B CLEC10A ADAMTSL2 | 6.60e-05 | 738 | 78 | 10 | MM17058 |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 7.04e-05 | 27 | 78 | 3 | MM643 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | IL34 PAPPA2 ADAM21 WNT8B ADAMTS15 PAPPA SEMA5A MUC5B CLEC10A ADAMTSL2 | 7.62e-05 | 751 | 78 | 10 | M5885 |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 1.18e-04 | 32 | 78 | 3 | M5903 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | EPHB4 ADORA2B PPARGC1B CD163L1 TENT5A SEMA5A ADGRF5 SVEP1 NOTCH2 NOTCH3 | 1.22e-04 | 795 | 78 | 10 | M39050 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.88e-04 | 399 | 78 | 7 | M41172 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 2.25e-04 | 289 | 78 | 6 | MM1238 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 2.31e-04 | 185 | 78 | 5 | MM1072 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.39e-04 | 703 | 78 | 9 | MM1055 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 2.42e-04 | 8 | 78 | 2 | M9884 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 2.45e-04 | 555 | 78 | 8 | M2343 | |
| Coexpression | GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.55e-04 | 189 | 78 | 5 | M5326 | |
| Coexpression | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP | 3.10e-04 | 9 | 78 | 2 | M18679 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 3.10e-04 | 9 | 78 | 2 | M9630 | |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP | 3.16e-04 | 198 | 78 | 5 | M5083 | |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP | 3.16e-04 | 198 | 78 | 5 | M3241 | |
| Coexpression | GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 3.31e-04 | 200 | 78 | 5 | M7758 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN | 3.31e-04 | 200 | 78 | 5 | M5186 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN | 3.31e-04 | 200 | 78 | 5 | M4375 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP26-1 KRTAP10-1 KRTAP10-2 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 8.54e-09 | 146 | 80 | 7 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.54e-08 | 186 | 80 | 7 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.54e-08 | 186 | 80 | 7 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-08 | 196 | 80 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-08 | 196 | 80 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 6.72e-08 | 197 | 80 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 6.72e-08 | 197 | 80 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-07 | 163 | 80 | 6 | 73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-07 | 169 | 80 | 6 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.57e-07 | 171 | 80 | 6 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-07 | 172 | 80 | 6 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-07 | 173 | 80 | 6 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.31e-07 | 178 | 80 | 6 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.58e-07 | 179 | 80 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|Mesenchymal_cells / Lineage and Cell class | 9.16e-07 | 181 | 80 | 6 | 1cfb03eb03a37b036b4eeacec69c9b8163af1ee4 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.11e-06 | 187 | 80 | 6 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-06 | 188 | 80 | 6 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 192 | 80 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 192 | 80 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.33e-06 | 193 | 80 | 6 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.33e-06 | 193 | 80 | 6 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-06 | 193 | 80 | 6 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 193 | 80 | 6 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.37e-06 | 194 | 80 | 6 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 194 | 80 | 6 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 194 | 80 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 195 | 80 | 6 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 196 | 80 | 6 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 197 | 80 | 6 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.50e-06 | 197 | 80 | 6 | 5bf4d964a9ee82002d3bc9ba1f020902eb96de7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 197 | 80 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-06 | 198 | 80 | 6 | 7b61f427ed5ca8ad563e5f112fba950a24c9d956 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-06 | 198 | 80 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-06 | 199 | 80 | 6 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | ILEUM-inflamed-(7)_ACKR1+_endothelial_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.59e-06 | 199 | 80 | 6 | 5c799115a6e95bcd896e4ad10bd272705c9a4e2c | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.59e-06 | 199 | 80 | 6 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-06 | 199 | 80 | 6 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 200 | 80 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 200 | 80 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.64e-06 | 200 | 80 | 6 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.64e-06 | 200 | 80 | 6 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.64e-06 | 200 | 80 | 6 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-06 | 138 | 80 | 5 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-06 | 152 | 80 | 5 | 27718e92715ddc80f28b457a5d6d6a3ac2b205d2 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.16e-06 | 156 | 80 | 5 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 157 | 80 | 5 | c8f516d3f5622202d3f8514f68614cd86ea3f667 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 157 | 80 | 5 | 4862a11ab8df27d26b4f1c1785e544a2d5b6db6e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.45e-06 | 157 | 80 | 5 | a98d06cef80bfe8481b0940abce2b29675e45812 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.45e-06 | 157 | 80 | 5 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 157 | 80 | 5 | a0ec1628ce29841889f1d9d4ee9422921af7b0b5 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 159 | 80 | 5 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 161 | 80 | 5 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 161 | 80 | 5 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 163 | 80 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 163 | 80 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 165 | 80 | 5 | 2477b0f1a0ea26184cf3cc4a9ffcdfa825cbc615 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-05 | 166 | 80 | 5 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-05 | 166 | 80 | 5 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-05 | 167 | 80 | 5 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.31e-05 | 168 | 80 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 169 | 80 | 5 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 175 | 80 | 5 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 175 | 80 | 5 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-05 | 176 | 80 | 5 | 7762e5d7c11756da605a604a289216bb53e25869 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 177 | 80 | 5 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 177 | 80 | 5 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 177 | 80 | 5 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 178 | 80 | 5 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 1.73e-05 | 178 | 80 | 5 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 178 | 80 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 180 | 80 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 180 | 80 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 1.88e-05 | 181 | 80 | 5 | 921e917f83105896ad8918dc134b871708024021 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 181 | 80 | 5 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-05 | 182 | 80 | 5 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-05 | 182 | 80 | 5 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 2.03e-05 | 184 | 80 | 5 | 3cec28ff076fa53d034428de2bb1a237e0c1568c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 184 | 80 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 184 | 80 | 5 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 184 | 80 | 5 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 185 | 80 | 5 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 185 | 80 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 185 | 80 | 5 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-05 | 185 | 80 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 2.14e-05 | 186 | 80 | 5 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 187 | 80 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 187 | 80 | 5 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 187 | 80 | 5 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 187 | 80 | 5 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 187 | 80 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 187 | 80 | 5 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.20e-05 | 187 | 80 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.20e-05 | 187 | 80 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.20e-05 | 187 | 80 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 187 | 80 | 5 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 188 | 80 | 5 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Promonocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 188 | 80 | 5 | 2ae945d96a011f246d04a42bcd6ef443232b03f4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.25e-05 | 188 | 80 | 5 | fbf176b48b89c234e4e1e64739afc836bed78a96 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-05 | 189 | 80 | 5 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 189 | 80 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | SELE AMY2B FCGBP ASGR2 CFP MUC5B C4BPB TNFRSF10C PGC LDLR CD163 MSMB | 7.18e-05 | 835 | 43 | 12 | MODULE_88 |
| Computational | Neighborhood of EGFR | 2.73e-04 | 32 | 43 | 3 | GNF2_EGFR | |
| Computational | Lung genes. | 2.76e-04 | 434 | 43 | 8 | MODULE_5 | |
| Computational | Genes in the cancer module 55. | SELE AMY2B ASGR2 CFP MUC5B C4BPB TNFRSF10C PGC LDLR CD163 MSMB | 3.22e-04 | 832 | 43 | 11 | MODULE_55 |
| Computational | Neighborhood of IGFBP1 | 3.57e-04 | 35 | 43 | 3 | GNF2_IGFBP1 | |
| Computational | Cell adhesion. | 3.88e-04 | 36 | 43 | 3 | MODULE_410 | |
| Computational | Genes in the cancer module 96. | 4.21e-04 | 37 | 43 | 3 | MODULE_96 | |
| Computational | Neighborhood of MMP11 | 6.14e-04 | 42 | 43 | 3 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 8.03e-04 | 46 | 43 | 3 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 9.66e-04 | 49 | 43 | 3 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.03e-03 | 50 | 43 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2 | |
| Drug | trestatin A | 1.50e-16 | 9 | 78 | 7 | CID003054994 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.48e-12 | 6 | 78 | 5 | CID003083414 | |
| Drug | R 623 | 2.48e-12 | 6 | 78 | 5 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 2.48e-12 | 6 | 78 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.48e-12 | 6 | 78 | 5 | CID000127364 | |
| Drug | CNP-G3 | 2.48e-12 | 6 | 78 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 8.65e-12 | 7 | 78 | 5 | CID000174858 | |
| Drug | BG5P | 8.65e-12 | 7 | 78 | 5 | CID003082752 | |
| Drug | boric acid gel | 2.30e-11 | 8 | 78 | 5 | CID003016474 | |
| Drug | desethylaprophen | 2.30e-11 | 8 | 78 | 5 | CID000163919 | |
| Drug | azintamide | 2.30e-11 | 8 | 78 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 5.16e-11 | 9 | 78 | 5 | CID000194237 | |
| Drug | AC1LAC07 | 1.03e-10 | 10 | 78 | 5 | CID000485275 | |
| Drug | Glc)4 | 1.03e-10 | 10 | 78 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 1.03e-10 | 10 | 78 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 1.03e-10 | 10 | 78 | 5 | CID000118008 | |
| Drug | 2-nitropropyl acetate | 1.27e-10 | 4 | 78 | 4 | CID013573844 | |
| Drug | N-PMT | 1.27e-10 | 4 | 78 | 4 | CID000194224 | |
| Drug | Dembrexine | 1.27e-10 | 4 | 78 | 4 | CID000072009 | |
| Drug | g lw | 1.27e-10 | 4 | 78 | 4 | CID000444139 | |
| Drug | AC1MQT4V | 1.27e-10 | 4 | 78 | 4 | CID003482066 | |
| Drug | beta-santalene | 1.27e-10 | 4 | 78 | 4 | CID000010534 | |
| Drug | SAIB-SG | 1.27e-10 | 4 | 78 | 4 | CID002735139 | |
| Drug | validamycin D | 1.88e-10 | 11 | 78 | 5 | CID000166726 | |
| Drug | FG5P | 1.88e-10 | 11 | 78 | 5 | CID000127486 | |
| Drug | CNP-G5 | 1.88e-10 | 11 | 78 | 5 | CID000127309 | |
| Drug | HgI2 | 1.88e-10 | 11 | 78 | 5 | CID000024485 | |
| Drug | 2C KM | 1.88e-10 | 11 | 78 | 5 | CID009549196 | |
| Drug | azaprophen | 3.22e-10 | 12 | 78 | 5 | CID000129486 | |
| Drug | 8a-c | 5.22e-10 | 13 | 78 | 5 | CID000066085 | |
| Drug | methyl 1'-epiacarviosin | 5.22e-10 | 13 | 78 | 5 | CID000197426 | |
| Drug | isoacarbose | 5.22e-10 | 13 | 78 | 5 | CID000449165 | |
| Drug | actinidine | 6.35e-10 | 5 | 78 | 4 | CID000068231 | |
| Drug | Deposiston | 6.35e-10 | 5 | 78 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 6.35e-10 | 5 | 78 | 4 | CID010358258 | |
| Drug | 2TAA | 6.35e-10 | 5 | 78 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 6.35e-10 | 5 | 78 | 4 | CID006449879 | |
| Drug | silver perchlorate | 6.35e-10 | 5 | 78 | 4 | CID000024562 | |
| Drug | lunularic acid | 6.35e-10 | 5 | 78 | 4 | CID000161413 | |
| Drug | himachalene | 6.35e-10 | 5 | 78 | 4 | CID000015095 | |
| Drug | AC1L4DZ4 | 6.35e-10 | 5 | 78 | 4 | CID000155287 | |
| Drug | Cyclodextrins | 8.10e-10 | 14 | 78 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 8.10e-10 | 14 | 78 | 5 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 8.10e-10 | 14 | 78 | 5 | CID000012074 | |
| Drug | AC1LA2MZ | 1.10e-09 | 58 | 78 | 7 | CID000460551 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.21e-09 | 15 | 78 | 5 | CID000173254 | |
| Drug | R625 | 1.37e-09 | 33 | 78 | 6 | CID000072375 | |
| Drug | 4-APP | 1.58e-09 | 61 | 78 | 7 | CID000075420 | |
| Drug | gamma-cyclodextrin | 1.76e-09 | 16 | 78 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 1.76e-09 | 16 | 78 | 5 | CID003085308 | |
| Drug | 2-amino-6-picoline | 1.90e-09 | 6 | 78 | 4 | CID000015765 | |
| Drug | phenol blue | 1.90e-09 | 6 | 78 | 4 | CID000075078 | |
| Drug | Gu-4 | 1.90e-09 | 6 | 78 | 4 | CID000448679 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 1.90e-09 | 6 | 78 | 4 | CID009577343 | |
| Drug | Borane dimethylamine complex | 1.90e-09 | 6 | 78 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 1.90e-09 | 6 | 78 | 4 | CID000092801 | |
| Drug | AC1OAGH8 | 1.90e-09 | 6 | 78 | 4 | CID006857368 | |
| Drug | vermella | 1.90e-09 | 6 | 78 | 4 | CID000203726 | |
| Drug | hymenin | 1.90e-09 | 6 | 78 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 1.90e-09 | 6 | 78 | 4 | CID000011615 | |
| Drug | trimitan | 3.43e-09 | 18 | 78 | 5 | CID000005561 | |
| Drug | aprophen | 3.43e-09 | 18 | 78 | 5 | CID000071128 | |
| Drug | 3KBG5CNP | 4.43e-09 | 7 | 78 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 4.43e-09 | 7 | 78 | 4 | CID000071762 | |
| Drug | Paramax | 4.43e-09 | 7 | 78 | 4 | CID000156411 | |
| Drug | methyl blue | 4.43e-09 | 7 | 78 | 4 | CID011969534 | |
| Drug | amino-methyl | 4.43e-09 | 7 | 78 | 4 | CID000142005 | |
| Drug | pg 6 | 6.17e-09 | 20 | 78 | 5 | CID000070931 | |
| Drug | AC1L3XPY | 8.08e-09 | 21 | 78 | 5 | CID000124005 | |
| Drug | AC1NSVJM | 8.83e-09 | 8 | 78 | 4 | CID005317411 | |
| Drug | theodrenaline | 8.83e-09 | 8 | 78 | 4 | CID000071857 | |
| Drug | N-vinylcaprolactam | 8.83e-09 | 8 | 78 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 8.83e-09 | 8 | 78 | 4 | CID000146692 | |
| Drug | acrinor | 8.83e-09 | 8 | 78 | 4 | CID005489637 | |
| Drug | rhodanile blue | 8.83e-09 | 8 | 78 | 4 | CID000073372 | |
| Drug | NSC300622 | 8.83e-09 | 8 | 78 | 4 | CID000028426 | |
| Drug | maltosaccharide | 1.04e-08 | 22 | 78 | 5 | CID005461034 | |
| Drug | Atonik | 1.58e-08 | 9 | 78 | 4 | CID000069471 | |
| Drug | GSAD | 1.58e-08 | 9 | 78 | 4 | CID009909127 | |
| Drug | GU-3 | 1.58e-08 | 9 | 78 | 4 | CID000448687 | |
| Drug | zingiberene | 1.58e-08 | 9 | 78 | 4 | CID000092776 | |
| Drug | H 187 | 1.58e-08 | 9 | 78 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 1.58e-08 | 9 | 78 | 4 | CID000024864 | |
| Drug | Panose B | 1.67e-08 | 24 | 78 | 5 | CID000439297 | |
| Drug | CID439354 | 2.09e-08 | 25 | 78 | 5 | CID000439354 | |
| Drug | I ZE | 2.63e-08 | 10 | 78 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 2.63e-08 | 10 | 78 | 4 | CID000012135 | |
| Drug | CG-120 | 2.63e-08 | 10 | 78 | 4 | CID000171403 | |
| Drug | naphthalene-1,3,6,8-tetrol | 2.63e-08 | 10 | 78 | 4 | CID000440202 | |
| Drug | eicosa-11,14-dienoic acid | 2.63e-08 | 10 | 78 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 2.63e-08 | 10 | 78 | 4 | CID000126789 | |
| Drug | Alfadexum | 3.01e-08 | 54 | 78 | 6 | CID000024796 | |
| Drug | AC1N3UXZ | 3.87e-08 | 3 | 78 | 3 | CID004118625 | |
| Drug | AMO-1618 | 4.13e-08 | 11 | 78 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 4.13e-08 | 11 | 78 | 4 | CID000430710 | |
| Drug | Tempamine | 4.13e-08 | 11 | 78 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 4.13e-08 | 11 | 78 | 4 | CID000164608 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 5.52e-08 | 30 | 78 | 5 | CID005373003 | |
| Drug | chitosan | 6.18e-08 | 12 | 78 | 4 | CID000071853 | |
| Drug | Avenin | 6.18e-08 | 12 | 78 | 4 | CID000095924 | |
| Disease | alpha-amylase 1 measurement | 4.30e-09 | 9 | 73 | 4 | EFO_0801371 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 5.05e-07 | 7 | 73 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 5.05e-07 | 7 | 73 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 9.00e-07 | 30 | 73 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 1.42e-05 | 59 | 73 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 1.42e-05 | 59 | 73 | 4 | C0037286 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.83e-05 | 24 | 73 | 3 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 3.63e-05 | 26 | 73 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Glioblastoma | 4.50e-05 | 79 | 73 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 5.73e-05 | 84 | 73 | 4 | C0334588 | |
| Disease | kallikrein-7 measurement | 6.01e-05 | 5 | 73 | 2 | EFO_0008195 | |
| Disease | liver fibrosis measurement | 6.28e-05 | 86 | 73 | 4 | EFO_0010576 | |
| Disease | intestinal cancer (implicated_via_orthology) | 6.84e-05 | 32 | 73 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 1.09e-04 | 99 | 73 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | Hypercholesterolemia | 1.25e-04 | 39 | 73 | 3 | C0020443 | |
| Disease | LDL cholesterol change measurement | 1.26e-04 | 7 | 73 | 2 | EFO_0007804 | |
| Disease | Polysyndactyly | 1.26e-04 | 7 | 73 | 2 | C0265553 | |
| Disease | Familial hypercholesterolemia | 1.67e-04 | 8 | 73 | 2 | cv:C0020445 | |
| Disease | Syndactyly | 1.67e-04 | 8 | 73 | 2 | C0039075 | |
| Disease | Glioblastoma Multiforme | 1.69e-04 | 111 | 73 | 4 | C1621958 | |
| Disease | hemangiopericytoma (is_marker_for) | 2.15e-04 | 9 | 73 | 2 | DOID:264 (is_marker_for) | |
| Disease | Hematuria | 2.15e-04 | 9 | 73 | 2 | C0018965 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.68e-04 | 10 | 73 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.68e-04 | 10 | 73 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | polyunsaturated fatty acid measurement | 3.19e-04 | 131 | 73 | 4 | EFO_0010733 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 5.32e-04 | 150 | 73 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 5.39e-04 | 14 | 73 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | Coronary Arteriosclerosis | 5.68e-04 | 65 | 73 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 5.68e-04 | 65 | 73 | 3 | C1956346 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 6.21e-04 | 15 | 73 | 2 | C0496930 | |
| Disease | Tinnitus, response to cisplatin | 6.21e-04 | 15 | 73 | 2 | GO_0072718, HP_0000360 | |
| Disease | Benign neoplasm of bladder | 6.21e-04 | 15 | 73 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 6.21e-04 | 15 | 73 | 2 | C0154091 | |
| Disease | response to statin, LDL cholesterol change measurement | 6.21e-04 | 15 | 73 | 2 | EFO_0007804, GO_0036273 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 7.08e-04 | 16 | 73 | 2 | OBA_2045195 | |
| Disease | Lipidemias | 8.02e-04 | 17 | 73 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 8.02e-04 | 17 | 73 | 2 | C0020473 | |
| Disease | COVID-19, mortality | 8.49e-04 | 170 | 73 | 4 | EFO_0004352, MONDO_0100096 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 9.00e-04 | 18 | 73 | 2 | OBA_2045175 | |
| Disease | Carcinoma of bladder | 9.00e-04 | 18 | 73 | 2 | C0699885 | |
| Disease | Hypercholesterolemia, Familial | 9.00e-04 | 18 | 73 | 2 | C0020445 | |
| Disease | anorectal malformation | 1.00e-03 | 19 | 73 | 2 | MONDO_0019938 | |
| Disease | fumarate measurement | 1.23e-03 | 21 | 73 | 2 | EFO_0010480 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 1.23e-03 | 21 | 73 | 2 | EFO_0022246 | |
| Disease | Malignant neoplasm of breast | 1.30e-03 | 1074 | 73 | 9 | C0006142 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.46e-03 | 197 | 73 | 4 | EFO_0005680 | |
| Disease | clinical and behavioural ideal cardiovascular health | 1.48e-03 | 23 | 73 | 2 | EFO_0007654 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.51e-03 | 91 | 73 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | Obesity | 1.69e-03 | 205 | 73 | 4 | C0028754 | |
| Disease | Squamous cell carcinoma of esophagus | 1.71e-03 | 95 | 73 | 3 | C0279626 | |
| Disease | Cerebral Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0750936 | |
| Disease | Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.75e-03 | 25 | 73 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.75e-03 | 25 | 73 | 2 | C0338070 | |
| Disease | Colorectal Carcinoma | 1.75e-03 | 702 | 73 | 7 | C0009402 | |
| Disease | Heart valve disease | 1.89e-03 | 26 | 73 | 2 | C0018824 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 1.89e-03 | 26 | 73 | 2 | OBA_2045194 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.89e-03 | 26 | 73 | 2 | OBA_2045191 | |
| Disease | Gemistocytic astrocytoma | 1.89e-03 | 26 | 73 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.89e-03 | 26 | 73 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.89e-03 | 26 | 73 | 2 | C0334582 | |
| Disease | L lactate dehydrogenase measurement | 1.89e-03 | 26 | 73 | 2 | EFO_0004808 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 1.89e-03 | 26 | 73 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | Mammary Carcinoma, Human | 1.92e-03 | 525 | 73 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.92e-03 | 525 | 73 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 1.95e-03 | 527 | 73 | 6 | C1458155 | |
| Disease | obsessive-compulsive disorder | 1.98e-03 | 100 | 73 | 3 | EFO_0004242 | |
| Disease | obesity (implicated_via_orthology) | 2.01e-03 | 215 | 73 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Anaplastic astrocytoma | 2.04e-03 | 27 | 73 | 2 | C0334579 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.15e-03 | 103 | 73 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | Breast Carcinoma | 2.17e-03 | 538 | 73 | 6 | C0678222 | |
| Disease | osteoarthritis (is_implicated_in) | 2.19e-03 | 28 | 73 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | Child Development Disorders, Specific | 2.35e-03 | 29 | 73 | 2 | C0085997 | |
| Disease | Child Development Deviations | 2.35e-03 | 29 | 73 | 2 | C0085996 | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 2.35e-03 | 29 | 73 | 2 | OBA_2045183 | |
| Disease | pappalysinâ1 measurement | 2.35e-03 | 29 | 73 | 2 | EFO_0010618 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EQQACSHGCWSQPAE | 116 | Q9UK28 | |
| APGETGSVICWCDQS | 86 | Q8N814 | |
| TNNCTEPWDGTTNES | 151 | P29275 | |
| CNNTALCPVHGVWEE | 336 | O60242 | |
| QEVNECDLPEWCNGT | 466 | Q9UKJ8 | |
| GSQRTCCPVNWVEHQ | 171 | P07307 | |
| SPVQDDTTSFGWLCC | 1241 | Q86UK0 | |
| PSTESCCVAQARVQW | 11 | A0A096LPI5 | |
| TINPDTTCGNDWVCE | 386 | P0DTE7 | |
| TINPDTTCGNDWVCE | 386 | P0DTE8 | |
| TINPDTTCGNDWVCE | 386 | P0DUB6 | |
| TINPDTTCGNDWVCE | 386 | P19961 | |
| DDVSCIGNESNIWDC | 541 | Q9NR16 | |
| ETQACGEPCPTWELS | 886 | Q8TE58 | |
| TTVVTTGCEPQCAWS | 4121 | Q9HC84 | |
| NQDNCTWSKEVCHPD | 326 | Q4KMQ2 | |
| TINPDTTCGNDWVCE | 386 | P04746 | |
| CPPQWTGQFCTEDVD | 286 | Q04721 | |
| VCPTGWQGQTCEVDI | 856 | P46531 | |
| ECTSGWTGQNCSEEI | 796 | Q5T1H1 | |
| WTGQNCSEEINECDS | 801 | Q5T1H1 | |
| EDGQWAEQPVTGCSC | 241 | P54760 | |
| ETLAESTWQCPPCDE | 91 | Q8WW33 | |
| CPEQWVGATCQLDAN | 411 | Q9Y219 | |
| WEGRTCTHNTNDCNP | 781 | Q9Y219 | |
| TVSEQSEPSAECWQN | 2691 | Q2LD37 | |
| QVTVACEEGWTLTGC | 621 | Q8NBP7 | |
| QCPPEWTGQFCTEDV | 261 | Q9UM47 | |
| WTGQFCTEDVDECQL | 266 | Q9UM47 | |
| WTGESCSQNIDDCAT | 306 | Q9UM47 | |
| SFTGPQCQTLVDWCS | 991 | Q9UM47 | |
| GWCLESSQCQDLTTE | 26 | P01189 | |
| TSQGQWTEEVPSCQV | 476 | P16581 | |
| NWSSPEPTCQVIQCE | 246 | P14151 | |
| NCTGPPCDRQWTVSD | 731 | Q86TH1 | |
| SEGQCIPNSWVCDQD | 76 | P98164 | |
| IPQSWVCDGDVDCTD | 2966 | P98164 | |
| CIPESWQCDTFNDCE | 3606 | P98164 | |
| SEDGAVLPQWLCSNC | 2176 | Q07864 | |
| SWQGDDCSVDVNECL | 1016 | Q9ULI3 | |
| CNTAVPCPVDGEWDS | 306 | P27918 | |
| QDGSWQEGACVPVTC | 1401 | Q13219 | |
| HPINSEWQTDNCETC | 46 | P08118 | |
| ISSCWCQGSVQDDAP | 266 | C9JSJ3 | |
| PELQCNFETGICNWE | 861 | Q5VYJ5 | |
| QSCEPFQADGWCDTI | 1731 | Q9BXP8 | |
| CVPRWQTCISNTDDA | 541 | P0DPD8 | |
| LNWQDCEVPSPQSCS | 186 | Q6ZMJ4 | |
| VDSPDSCQVSGGDWC | 1066 | Q9BWV1 | |
| SVCQGETSWLEENCD | 131 | O14638 | |
| QHGCQPVSTAECQAW | 2061 | Q9Y6R7 | |
| WRAQVGCEITCPENS | 3141 | Q9Y6R7 | |
| CQPVSTAECQAWGDP | 4466 | Q9Y6R7 | |
| ESQWDETTCGLAVCQ | 6 | Q8TAL5 | |
| ENCCNWVSSSEPLDT | 341 | Q8WUF8 | |
| EQQCVDGEWSSALPV | 176 | P20851 | |
| CVDGEWTTLPTCVEQ | 251 | Q9BXR6 | |
| ISPSGWDCVDVNECE | 1336 | Q14767 | |
| SACSDSWQVDACPES | 11 | P60331 | |
| SACTNSWQVDDCPES | 11 | P60368 | |
| LPGSCDSCSDSWQVD | 16 | P60372 | |
| LPGSCDSCSDSWQVD | 21 | P60371 | |
| LPGSCDSCSDSWQVD | 21 | P60409 | |
| LPGSCDSCSDSWQVD | 16 | P60413 | |
| WVTDNCQETCGEPTS | 51 | Q6PEX3 | |
| VESCSNLTWCTNPQG | 2151 | Q8IWT3 | |
| CTSCLTSWQESEGQG | 401 | P22681 | |
| DSVSCQGHEPAIWQC | 331 | Q86VB7 | |
| GVTEDGWNCISCPSD | 106 | Q5HYA8 | |
| ARCWGTAETNVSCPQ | 41 | P14373 | |
| SSWSLCQLTCVNGED | 1421 | Q9UPZ6 | |
| DAGWTGSNCSEECPL | 381 | Q9UK23 | |
| TCFGELQWCPENSET | 56 | Q86YN6 | |
| AGANINACDSECWTP | 126 | Q96I34 | |
| WNGVSPSCLDVDECA | 1736 | Q4LDE5 | |
| EEALCNTQPCPESWS | 886 | Q13591 | |
| NVTTVCRPAGNEIWC | 106 | Q8IZF2 | |
| TEGTCCPVNWVEHQD | 176 | Q8IUN9 | |
| SGSCTTQTCWLQLPE | 186 | Q93098 | |
| LSAQNEGWDSPICTE | 26 | Q8WVN6 | |
| WCSEGCQAIVDTGTS | 266 | P20142 | |
| WVCTSGDPQDLAVTD | 451 | Q96N76 | |
| SECNCDESQWEPVCG | 461 | Q9NPD5 | |
| ENCGNPEHCLTTDWV | 26 | Q4KMG9 | |
| CPSGEVQVSNCTSWD | 131 | O14798 | |
| QWNETEPACRAVCSG | 581 | Q53EL9 | |
| TCDPNWTGPDCSNEI | 666 | Q9P273 | |
| PVIGTWDCDTCLVQN | 721 | P49790 | |
| LTNTCWNGCSTPDAE | 311 | Q9NX45 | |
| CESPTAHCNVLNWEQ | 56 | Q96IP4 | |
| NSSTCIPQLWACDND | 156 | P01130 | |
| VSALGECTCIPAQWQ | 36 | O75096 |